Final Report - IMEDGEN (Intracellular Methylases Delivery as therapeutic tool for carcinoma specific regulation of Gene expression)
Project ID: 17984Funded under: FP6-SME
This is the final report of the IMEDGEN consortium. The report notes that after 24 months the prototype of the new generation of drugs, the double-targeted carcinoma cell- and gene-specific DNA-modifying enzyme will be successfully tested in cell lines and animal models. Since the product is one of a kind, it strengthens the competitiveness in the field of all participating SMEs. It covers goal, technical and industrial results and publication results. An image of the logo is also included.
Download application/msword (101888)
Record Number: 11175 / Last updated on: 2011-04-14